인지질 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for phospholipids. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Phospholipids Market Size (2024E): USD 3.4 Billion
• Projected Market Value (2033F): USD 6.6 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 7.50%

Phospholipids Market - Report Scope:

Phospholipids play a crucial role in various industries, including pharmaceuticals, nutraceuticals, cosmetics, and food processing. These molecules serve as essential structural components of cell membranes and find applications in drug delivery systems, dietary supplements, and functional foods. The phospholipids market caters to diverse sectors, offering products such as phosphatidylcholine, phosphatidylserine, and phosphatidylethanolamine.

Market Growth Drivers:

The global phospholipids market is propelled by several key factors, including increasing demand for functional food ingredients and dietary supplements enriched with phospholipids due to their health benefits. The pharmaceutical industry's growing reliance on phospholipid-based drug delivery systems to enhance bioavailability and efficacy of drugs also drives market expansion. Moreover, advancements in extraction technologies and sustainable sourcing practices contribute to market growth by ensuring cost-effective production and environmental sustainability.

Market Restraints:

Despite promising growth prospects, the phospholipids market faces challenges related to regulatory complexities, particularly concerning health claims and product labeling. Stringent regulations governing the safety and efficacy of phospholipid-based products impose compliance burdens on manufacturers and limit market entry opportunities. Furthermore, fluctuating raw material prices and supply chain disruptions pose challenges for market players, impacting production costs and profitability.

Market Opportunities:

The phospholipids market presents significant growth opportunities driven by increasing consumer awareness about the health benefits of phospholipid-enriched products and expanding applications in novel therapeutic areas. The integration of phospholipids in skincare formulations and cosmetic products due to their emulsifying and moisturizing properties opens new avenues for market expansion. Strategic collaborations, research investments, and product innovation aimed at developing novel phospholipid formulations further enhance market competitiveness and sustainability.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global phospholipids market?
• Which applications and industries are driving phospholipid adoption across different market segments?
• How are technological advancements reshaping the competitive landscape of the phospholipids market?
• Who are the key players contributing to the phospholipids market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global phospholipids market?

Competitive Intelligence and Business Strategy:

Leading players in the global phospholipids market, including Cargill Incorporated, Croda International Plc., and Bunge Ltd., focus on innovation, product diversification, and strategic partnerships to gain a competitive edge. These companies invest in research and development to introduce advanced phospholipid formulations tailored to specific market needs, such as pharmaceutical-grade phospholipids and liposomal delivery systems. Collaboration with regulatory authorities and industry stakeholders facilitates market access and compliance with evolving regulatory standards, ensuring product safety and efficacy.

Key Companies Profiled:

• Cargill Incorporated
• Archer Daniels Midland Company
• Evonik Industries AG
• Croda International Plc
• Bunge Ltd.
• Kewpie Corporation
• Wilmar International Ltd.
• Lipoid GmbH
• Lecico GmbH
• Lasenor Emul SL
• VAV Life Sciences Pvt. Ltd
• American Lecithin Company
• Soja Protein a.d

Phospholipids Market Segmentation

By Type:

• Phosphatidylserine
• Phosphatidylcholine

By Source:

• Soy
• Sunflowers
• Eggs

By End Use:

• Food and Beverages
• Nutraceutical Supplements
• Pharmaceuticals

By Region:

• North America
• Latin America
• Europe
• South Asia Pacific
• East Asia
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Strategic Promotional Strategies

5. Global Market Demand Analysis 2019-2023 and Forecast, 2024-2033

• 5.1. Historical Market Volume (Tons) Analysis, 2019-2023
• 5.2. Current and Future Market Volume (Tons) Projections, 2024-2033
• 5.3. Y-o-Y Growth Trend Analysis

6. Global Market - Pricing Analysis

• 6.1. Regional Pricing Analysis by Source
• 6.2. Global Average Pricing Analysis Benchmark

7. Global Market Demand (in Value or Size in US$ Million) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Million) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Million) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

• 8.1. Macro-Economic Factors
  • 8.1.1. Global GDP Growth Outlook
  • 8.1.2. Global Population Growth
  • 8.1.3. Manufacturing Value Added by Key Countries
  • 8.1.4. Global Food and Beverage
  • 8.1.5. Global Cosmetic Industry Outlook
  • 8.1.6. Global Pharmaceutical Industry Overview
• 8.2. Forecast Factors - Relevance and Impact
  • 8.2.1. Top company's historical growth
  • 8.2.2. Growth of End User Sectors
  • 8.2.3. GDP Growth
  • 8.2.4. Growth of the Functional Foods Industry
  • 8.2.5. Research and Development Expenditure
  • 8.2.6. Clean Label and Ingredient Transparency
  • 8.2.7. Pricing Dynamics
  • 8.2.8. Increasing Consumption of Infant Formula-
  • 8.2.9. Increasing importance of certification
• 8.3. Value Chain Analysis
  • 8.3.1. Product Manufacturers
  • 8.3.2. List of Suppliers/ Distributors
  • 8.3.3. List of Probable End-use Industries
• 8.4. COVID-19 Crisis - Impact Assessment
  • 8.4.1. Current Statistics
  • 8.4.2. Short-Mid-Long Term Outlook
  • 8.4.3. Likely Rebound
• 8.5. Market Dynamics
  • 8.5.1. Drivers
  • 8.5.2. Restraints
  • 8.5.3. Opportunity Analysis
• 8.6. Phospholipid Production Process Overview
• 8.7. Key Applicable Regulations
• 8.8. Key Developments
• 8.9. Global Supply Vs. Demand Analysis

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Type

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Million) and Volume Analysis by Type, 2019-2023
• 9.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast by Type, 2024-2033
  • 9.3.1. Phosphatidylserine
  • 9.3.2. Phosphatidylcholine
  • 9.3.3. Others
• 9.4. Market Attractiveness Analysis by Type

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Source

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Million) and Volume Analysis by Source, 2019-2023
• 10.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast by Source, 2024-2033
  • 10.3.1. Soy
  • 10.3.2. Sunflower
  • 10.3.3. Egg
  • 10.3.4. Others
• 10.4. Market Attractiveness Analysis by Source

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Million) and Volume Analysis by End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast by End User, 2024-2033
  • 11.3.1. Food and beverage
  • 11.3.2. Nutraceutical Supplements
  • 11.3.3. Pharmaceuticals
  • 11.3.4. Others
• 11.4. Market Attractiveness Analysis by End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Million) and Volume Analysis by Region, 2019-2023
• 12.3. Current Market Size (US$ Million) and Volume Analysis and Forecast by Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. South Asia and Pacific
  • 12.3.5. East Asia
  • 12.3.6. Middle East and Africa (Middle East and Africa)
• 12.4. Market Attractiveness Analysis by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Pricing Analysis
• 13.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2019-2023
• 13.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2024-2033
  • 13.4.1. by Country
    • 13.4.1.1. U.S.
    • 13.4.1.2. Canada
  • 13.4.2. by Type
  • 13.4.3. by Source
  • 13.4.4. by End User
• 13.5. Market Attractiveness Analysis
  • 13.5.1. by Country
  • 13.5.2. by Type
  • 13.5.3. by Source
  • 13.5.4. by End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Pricing Analysis
• 14.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2019-2023
• 14.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2024-2033
  • 14.4.1. by Country
    • 14.4.1.1. Brazil
    • 14.4.1.2. Mexico
    • 14.4.1.3. Rest of Latin America
  • 14.4.2. by Type
  • 14.4.3. by Source
  • 14.4.4. by End User
• 14.5. Market Attractiveness Analysis
  • 14.5.1. by Country
  • 14.5.2. by Type
  • 14.5.3. by Source
  • 14.5.4. by End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Pricing Analysis
• 15.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2019-2023
• 15.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2024-2033
  • 15.4.1. by Country
    • 15.4.1.1. Germany
    • 15.4.1.2. Italy
    • 15.4.1.3. France
    • 15.4.1.4. U.K.
    • 15.4.1.5. Spain
    • 15.4.1.6. BENELUX
    • 15.4.1.7. Russia
    • 15.4.1.8. Rest of Europe
  • 15.4.2. by Type
  • 15.4.3. by Source
  • 15.4.4. by End User
• 15.5. Market Attractiveness Analysis
  • 15.5.1. by Country
  • 15.5.2. by Type
  • 15.5.3. by Source
  • 15.5.4. by End User

16. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Pricing Analysis
• 16.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2019-2023
• 16.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2024-2033
  • 16.4.1. by Country
    • 16.4.1.1. India
    • 16.4.1.2. ASEAN
    • 16.4.1.3. Oceania
    • 16.4.1.4. Rest of South Asia and Pacific
  • 16.4.2. by Type
  • 16.4.3. by Source
  • 16.4.4. by End User
• 16.5. Market Attractiveness Analysis
  • 16.5.1. by Country
  • 16.5.2. by Type
  • 16.5.3. by Source
  • 16.5.4. by End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Pricing Analysis
• 17.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2019-2023
• 17.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2024-2033
  • 17.4.1. by Country
    • 17.4.1.1. China
    • 17.4.1.2. Japan
    • 17.4.1.3. South Korea
  • 17.4.2. by Type
  • 17.4.3. by Source
  • 17.4.4. by End User
• 17.5. Market Attractiveness Analysis
  • 17.5.1. by Country
  • 17.5.2. by Type
  • 17.5.3. by Source
  • 17.5.4. by End User

18. Middle East and Africa Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Pricing Analysis
• 18.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2019-2023
• 18.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2024-2033
  • 18.4.1. by Country
    • 18.4.1.1. Gulf co-operation council countries
    • 18.4.1.2. Turkey
    • 18.4.1.3. Northern Africa
    • 18.4.1.4. South Africa
    • 18.4.1.5. Rest of Middle East and Africa
  • 18.4.2. by Type
  • 18.4.3. by Source
  • 18.4.4. by End User
• 18.5. Market Attractiveness Analysis
  • 18.5.1. by Country
  • 18.5.2. by Type
  • 18.5.3. by Source
  • 18.5.4. by End User

19. Country Wise Analysis 2024-2033

• 19.1. U.S. Market Analysis
  • 19.1.1. by Type
  • 19.1.2. by Source
  • 19.1.3. by End User
• 19.2. Canada Analysis
  • 19.2.1. by Type
  • 19.2.2. by Source
  • 19.2.3. by End User
• 19.3. Mexico Analysis
  • 19.3.1. by Type
  • 19.3.2. by Source
  • 19.3.3. by End User
• 19.4. Brazil Analysis
  • 19.4.1. by Type
  • 19.4.2. by Source
  • 19.4.3. by End User
• 19.5. Germany Analysis
  • 19.5.1. by Type
  • 19.5.2. by Source
  • 19.5.3. by End User
• 19.6. Italy Analysis
  • 19.6.1. by Type
  • 19.6.2. by Source
  • 19.6.3. by End User
• 19.7. France Analysis
  • 19.7.1. by Type
  • 19.7.2. by Source
  • 19.7.3. by End User
• 19.8. U.K. Analysis
  • 19.8.1. by Type
  • 19.8.2. by Source
  • 19.8.3. by End User
• 19.9. Spain Analysis
  • 19.9.1. by Type
  • 19.9.2. by Source
  • 19.9.3. by End User
• 19.10. Russia Analysis
  • 19.10.1. by Type
  • 19.10.2. by Source
  • 19.10.3. by End User
• 19.11. China Analysis
  • 19.11.1. by Type
  • 19.11.2. by Source
  • 19.11.3. by End User
• 19.12. Japan Analysis
  • 19.12.1. by Type
  • 19.12.2. by Source
  • 19.12.3. by End User
• 19.13. South Korea Analysis
  • 19.13.1. by Type
  • 19.13.2. by Source
  • 19.13.3. by End User
• 19.14. India Analysis
  • 19.14.1. by Type
  • 19.14.2. by Source
  • 19.14.3. by End User
• 19.15. Association of Southeast Asian Nations (ASEAN) Analysis
  • 19.15.1. by Type
  • 19.15.2. by Source
  • 19.15.3. by End User
• 19.16. Australia and New Zealand Analysis
  • 19.16.1. by Type
  • 19.16.2. by Source
  • 19.16.3. by End User
• 19.17. Turkiye Analysis
  • 19.17.1. by Type
  • 19.17.2. by Source
  • 19.17.3. by End User
• 19.18. South Africa Analysis
  • 19.18.1. by Type
  • 19.18.2. by Source
  • 19.18.3. by End User

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies (De-Aromatic Solvents)
• 20.2. Market Concentration
• 20.3. Market Share Analysis of Top Players

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. Cargill Incorporated
    • 21.3.1.1. Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.1.4. Sales Footprint
    • 21.3.1.5. Strategy Overview
  • 21.3.2. Archer Daniels Midland Company
    • 21.3.2.1. Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.2.4. Sales Footprint
    • 21.3.2.5. Strategy Overview
  • 21.3.3. Evonik Industries AG
    • 21.3.3.1. Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.3.4. Sales Footprint
    • 21.3.3.5. Strategy Overview
  • 21.3.4. Croda International Plc
    • 21.3.4.1. Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.4.4. Sales Footprint
    • 21.3.4.5. Strategy Overview
  • 21.3.5. Bunge Ltd.
    • 21.3.5.1. Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.5.4. Sales Footprint
    • 21.3.5.5. Strategy Overview
  • 21.3.6. Kewpie Corporation
    • 21.3.6.1. Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.6.4. Sales Footprint
    • 21.3.6.5. Strategy Overview
  • 21.3.7. Wilmar International Ltd.
    • 21.3.7.1. Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.7.4. Sales Footprint
    • 21.3.7.5. Strategy Overview
  • 21.3.8. Lipoid GmbH
    • 21.3.8.1. Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.8.4. Sales Footprint
    • 21.3.8.5. Strategy Overview
  • 21.3.9. Lecico GmbH
    • 21.3.9.1. Overview
    • 21.3.9.2. Product Portfolio
    • 21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.9.4. Sales Footprint
    • 21.3.9.5. Strategy Overview
  • 21.3.10. Lasenor Emul SL
    • 21.3.10.1. Overview
    • 21.3.10.2. Product Portfolio
    • 21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.10.4. Sales Footprint
    • 21.3.10.5. Strategy Overview
  • 21.3.11. VAV Life Sciences Pvt. Ltd
    • 21.3.11.1. Overview
    • 21.3.11.2. Product Portfolio
    • 21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.11.4. Sales Footprint
    • 21.3.11.5. Strategy Overview
  • 21.3.12. American Lecithin Company
    • 21.3.12.1. Overview
    • 21.3.12.2. Product Portfolio
    • 21.3.12.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.12.4. Sales Footprint
    • 21.3.12.5. Strategy Overview
  • 21.3.13. Soja Protein a.d
    • 21.3.13.1. Overview
    • 21.3.13.2. Product Portfolio
    • 21.3.13.3. Profitability by Market Segments (Product/Channel/Region)
    • 21.3.13.4. Sales Footprint
    • 21.3.13.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology